I Think I’m Ready for Y2K7
By Daniel R. Matlis On February 13, I wrote about Y2K7, so I thought it would be a good idea to heed my own advice […]
I Think I’m Ready for Y2K7 Read More »
By Daniel R. Matlis On February 13, I wrote about Y2K7, so I thought it would be a good idea to heed my own advice […]
I Think I’m Ready for Y2K7 Read More »
By Daniel R. Matlis On February 13th, I had the pleasure to participate in a panel at Furness High School in Philadelphia to expose students
I, Surgical Assist ROBOT Read More »
By Daniel R. Matlis On February 26, 2007 Microsoft’s CEO, Steve Ballmer, offered his view on the role of technology in healthcare during his remarks
By Daniel R. Matlis On February 26, 2007 Microsoft’s CEO, Steve Ballmer, offered his view on the role of technology in healthcare during his remarks
By Daniel R. Matlis The Kaiser Permanente Northern California Division of Research announced yesterday, February 14 2007, that it is launching one of the largest
Are you ready for Virtual Clinical Trials? Read More »
By Daniel R. Matlis Remember Y2K? Well, the world didn’t end, companies spent large budgets in Y2K remediation projects, and computer systems continued to function.
Are You Ready for Y2K7 Read More »
On September 22, 2006, the Institute of Medicine (IOM) issued a report in response to growing public concern with health risks posed by FDA approved
Drug Safety Takes Center Stage in Washington DC Read More »
By Daniel R. Matlis FDA Commissioner Dr. Andrew C. von Eschenbach recently announced the creation of the Office of the Chief Medical Officer. The position
FDA Moves Closer To Becoming An Information Broker Read More »
By Daniel R. Matlis No, it’s not insider trading. This is perfectly legal. Today, Siemens announced that it will acquire UGS Corporation. UGS’ software portfolio
Here Is A Tip That Can Make You 2.6 Billion Dollars Read More »
By Daniel R. Matlis No, it’s not insider trading. This is perfectly legal. Today, Siemens announced that it will acquire UGS Corporation. UGS’ software portfolio
Here Is A Tip That Can Make You 2.6 Billion Dollars Read More »
On December 2nd 2006, Pfizer announced that it had stopped all development and clinical trials for its cholesterol drug Torcetrapib. Torcetrapib was widely regarded as
Pfizer Plans To Eliminate 10,000 Jobs, Close 3 Manufacturing Plants and 5 R&D Sites Read More »
By Daniel R. Matlis On January 12th, I reported on FDA’s request for Pharmaceutical companies to confirm or repeat all pharmacokinetic studies conducted by MDS Pharma
FDA to Conduct Evaluation of Pharmacovigilance Systems Read More »